• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蒽环类药物向脂质体的远程载入。

Remote loading of anthracyclines into liposomes.

作者信息

Lewrick Felicitas, Süss Regine

机构信息

Department of Pharmaceutical Technology and Biopharmacy, Albert-Ludwigs University, Freiburg, Germany.

出版信息

Methods Mol Biol. 2010;605:139-45. doi: 10.1007/978-1-60327-360-2_9.

DOI:10.1007/978-1-60327-360-2_9
PMID:20072878
Abstract

The following chapter introduces a remote loading procedure for anthracyclines focussing on the well-established drug doxorubicin. The key advantage of remote loading is that it leads to higher drug to lipid ratios and encapsulation efficiencies compared to conventional passive trapping techniques like hydration of dried lipid films with aqueous drug solutions. The method presented is appropriate to produce sterile liposomal doxorubicin formulations with a final concentration of 2 mg/mL doxorubicin, which can be applied not only in vitro but also in vivo.

摘要

以下章节介绍了一种针对蒽环类药物的远程加载程序,重点是成熟药物阿霉素。远程加载的关键优势在于,与传统的被动捕获技术(如用药物水溶液水合干燥脂质膜)相比,它能实现更高的药物与脂质比例和包封效率。所介绍的方法适用于制备最终浓度为2mg/mL阿霉素的无菌脂质体阿霉素制剂,该制剂不仅可用于体外,也可用于体内。

相似文献

1
Remote loading of anthracyclines into liposomes.蒽环类药物向脂质体的远程载入。
Methods Mol Biol. 2010;605:139-45. doi: 10.1007/978-1-60327-360-2_9.
2
The liposomal formulation of doxorubicin.阿霉素的脂质体制剂。
Methods Enzymol. 2005;391:71-97. doi: 10.1016/S0076-6879(05)91004-5.
3
Cardiac profiles of liposomal anthracyclines: greater cardiac safety versus conventional doxorubicin?脂质体蒽环类药物的心脏特性:与传统阿霉素相比,心脏安全性更高?
Cancer. 2004 May 15;100(10):2052-63. doi: 10.1002/cncr.20207.
4
Liposomal doxorubicin.脂质体阿霉素
J Drug Target. 1996;4(3):129-40. doi: 10.3109/10611869609015970.
5
[The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes].阿霉素抗耐药隐形脂质体的体外细胞毒性和体内毒性
Yao Xue Xue Bao. 2005 May;40(5):475-80.
6
Cardiac safety of liposomal anthracyclines.脂质体蒽环类药物的心脏安全性。
Cardiovasc Toxicol. 2007;7(2):72-4. doi: 10.1007/s12012-007-0014-4.
7
Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.由冻干脂质体组成的脂质体阿霉素制剂试剂盒。
Anticancer Res. 2003 Jan-Feb;23(1A):439-42.
8
Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?两种聚乙二醇化脂质体阿霉素制剂的直接比较:曲线下面积(AUC)能否预测毒性和疗效?
J Control Release. 2007 Apr 2;118(2):204-15. doi: 10.1016/j.jconrel.2006.12.002. Epub 2006 Dec 8.
9
Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.抗CD19靶向脂质体阿霉素提高了小鼠B细胞淋巴瘤的治疗效果,并改善了不同药物释放速率的脂质体的毒性。
Clin Cancer Res. 2005 May 1;11(9):3567-73. doi: 10.1158/1078-0432.CCR-04-2517.
10
The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo.新型 EDTA 离子梯度法将柔红霉素包封于脂质体中,确保了药物在体外和体内的更好保留。
J Control Release. 2010 Aug 17;146(1):68-75. doi: 10.1016/j.jconrel.2010.05.021. Epub 2010 May 24.

引用本文的文献

1
Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids?基于脂质的纳米颗粒在推进抗癌生物碱的临床转化方面有前景吗?
Cancers (Basel). 2021 Oct 25;13(21):5346. doi: 10.3390/cancers13215346.
2
Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects.用于眼部疾病的脂质体药物递送系统——最新进展与未来前景
Nanomaterials (Basel). 2020 Jun 18;10(6):1191. doi: 10.3390/nano10061191.
3
Dorzolamide Loaded Niosomal Vesicles: Comparison of Passive and Remote Loading Methods.
载有dorzolamide的非离子表面活性剂囊泡:被动加载和远程加载方法的比较。
Iran J Pharm Res. 2017 Spring;16(2):413-422.
4
Microfluidic remote loading for rapid single-step liposomal drug preparation.用于快速单步脂质体药物制备的微流控远程加载
Lab Chip. 2014 Sep 7;14(17):3359-67. doi: 10.1039/c4lc00390j.
5
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension.脂质体法舒地尔,一种 rho 激酶抑制剂,用于肺动脉高压的肺选择性血管扩张的持续时间延长。
J Control Release. 2013 Apr 28;167(2):189-99. doi: 10.1016/j.jconrel.2013.01.011. Epub 2013 Jan 23.